Related Experiment Video
Updated: May 5, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Using Spent Brewer's Yeast to Encapsulate and Enhance the Bioavailability of Sonochemically Nanostructured Curcumin
Irina Kalinina1, Rinat Fatkullin1, Natalya Naumenko1
1Department of Food and Biotechnology, South Ural State University (National Research University), 76 Lenin Avenue, Chelyabinsk 454080, Russia.
Abstract:
This study is aimed at investigating the possibility of using spent cells of brewer's yeast Saccharomyces cerevisiae to encapsulate the plant antioxidant curcumin and the effect of such an approach on the bioavailability of BAS in an in vitro digestion model. Spent brewer's yeast is a significant volume organic waste that is difficult to dispose of, which makes additional options for its use very promising. Encapsulation of curcumin into spent yeast cells was carried out in a nanostructured manner. The encapsulation process was studied using laser dynamic light scattering, inverted and luminescence microscopy, and FTIR analysis. The efficiency and feasibility of curcumin encapsulation process was evaluated by determining the encapsulation efficiency index and modeling the in vitro digestion process. From these studies, it was found that spent yeast cells are capable of acting as a "delivery system" for curcumin. Encapsulation efficiencies of 47.7% can be achieved if curcumin is prenanostructured. Analysis of the potential bioavailability of the plant antioxidant in an in vitro gastric digestion model showed that the technology of encapsulation into yeast cells allows for curcumin retention of 79.5%.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioreactor Controls-III

